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Background. We observed that some patients with clinical leptospirosis supported by positive results of
rapid tests were negative for leptospirosis on the basis of our diagnostic gold standard, which involves isolation
of Leptospira species from blood culture and/or a positive result of a microscopic agglutination test (MAT).
We hypothesized that our reference standard was imperfect and used statistical modeling to investigate this
hypothesis.
Methods. Data for 1652 patients with suspected leptospirosis recruited during three observational studies and
one randomized control trial that described the application of culture, MAT, immunoﬂuorescence assay (IFA),
lateral ﬂow (LF) and/or PCR targeting the 16S rRNA gene were reevaluated using Bayesian latent class models
and random-effects meta-analysis.
Results. The estimated sensitivities of culture alone, MAT alone, and culture plus MAT (for which the result
was considered positive if one or both tests had a positive result) were 10.5% (95% credible interval [CrI],
2.7%–27.5%), 49.8% (95% CrI, 37.6%–60.8%), and 55.5% (95% CrI, 42.9%–67.7%), respectively. These low sensi-
tivities were present across all 4 studies. The estimated speciﬁcity of MAT alone (and of culture plus MAT) was
98.8% (95% CrI, 92.8%–100.0%). The estimated sensitivities and speciﬁcities of PCR (52.7% [95% CrI, 45.2%–
60.6%] and 97.2% [95% CrI, 92.0%–99.8%], respectively), lateral ﬂow test (85.6% [95% CrI, 77.5%–93.2%] and
96.2% [95% CrI, 87.7%–99.8%], respectively), and immunoﬂuorescence assay (45.5% [95% CrI, 33.3%–60.9%]
and 96.8% [95% CrI, 92.8%–99.8%], respectively) were considerably different from estimates in which culture plus
MAT was considered a perfect gold standard test.
Conclusions. Our ﬁndings show that culture plus MAT is an imperfect gold standard against which to
compare alterative tests for the diagnosis of leptospirosis. Rapid point-of-care tests for this infection would bring
an important improvement in patient care, but their future evaluation will require careful consideration of the
reference test(s) used and the inclusion of appropriate statistical models.
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The clinical manifestations of leptospirosis range from a mild
inﬂuenza-like illness to multiorgan failure and death. The
common signs and symptoms of this infection fail to discrimi-
nate leptospirosis from a range of other infectious diseases
that occur in the tropics, including dengue fever, malaria, and
rickettsial infection [1]. Although laboratory diagnosis has the
potential to guide the management of patients with leptospi-
rosis, this is not currently achieved in most regions of the
world because of a lack of point-of-care tests. Once such tests
become available, however, it will be important to ensure that
the diagnostic reference standard against which they are com-
pared during clinical evaluation is robust.
We have undertaken several therapeutic and diagnostic
evaluation studies involving patients presenting to hospitals in
Thailand with suspected leptospirosis [2–5]. The reference
tests used were a combination of culture for Leptospira species
and the microscopic agglutination test (MAT). Deﬁnite lepto-
spirosis was deﬁned as the isolation of Leptospira species from
a normally sterile site and/or a 4-fold increase in the MAT
titer between acute- and convalescent-phase serum samples or
a single MAT titer of ≥1:400. This is consistent with the pub-
lished recommendations of the World Health Organization
Leptospirosis Burden Epidemiology Reference Group [6].
We began to question the accuracy of the recommended ap-
proach after becoming increasingly aware that some patients
with suspected leptospirosis who had positive results of alterna-
tive tests, such as a real-time polymerase chain reaction (PCR)
targeting the gene encoding the 16S ribosomal RNA (rRNA)
subunit, a lateral ﬂow test, and/or an immunoﬂuorescence
assay (IFA), were negative for leptospirosis on the basis of our
reference standard. This was a consistent ﬁnding across differ-
ent studies in which we had obtained a convalescent-phase spe-
cimen from the majority of cases. We hypothesized that the
reference standard was imperfect and that the accuracy of alter-
native diagnostic tests, estimated using the gold standard, was
biased. We sought an appropriate statistical model with which
to determine the true accuracy of alternative tests in this
situation.
Bayesian latent class models have been increasingly used to
evaluate the true accuracy of diagnostic tests and do not require
the assumption that any test or combination of tests is
perfect [7,8]. The objective of this studywas to use Bayesian latent
class models to reanalyze individual-level data from 4 existing
data sets gathered during studies of patients presenting to the
hospital with suspected leptospirosis. On the basis of these ﬁnd-
ings, we estimated the true accuracy of a range of serological and
molecular diagnostic tests for leptospirosis and determined the
impact of an imperfect gold standard on the reported accuracies
of alternative tests. Information from all studies was combined
using Bayesian random-effects meta-analysis to further support
the observations from individual studies.
METHODS
We followed a standard protocol for meta-analyses [9], togeth-
er with the methods recommended by the Cochrane Diagnos-
tic Test Accuracy Working Group, the STARD (Standards for
the Reporting of Diagnostic Accuracy) statement, and the
PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-analyses) statement [10].
Search Strategy and Study Selection
Our aim was to reanalyze complete individual-level data sets
created by us during hospital-based studies of suspected lepto-
spirosis conducted in northeast Thailand between 2000 and
2010 (Table 1). All studies had undertaken prospective enroll-
ment of adult patients (age, >14 years) with suspected lepto-
spirosis and had used a combination of blood culture for
Leptospira species and MAT (hereafter, “culture plus MAT”)
as the diagnostic reference standard. Studies were selected if
individual-level data sets were available for analysis. For pa-
tients included in >1 study, only data from the ﬁrst study were
used in the analysis.
Ethics Statement
Ethical approval for all studies included in the analysis was
obtained from the Ministry of Public Health, Thailand, and
the Oxford Tropical Research Ethics Committee, United
Kingdom. Written inform consent was obtained from each
subject enrolled into these studies [2–5].
Diagnostic Tests
All diagnostic tests that were used in each study were evaluated.
In each study, blood was collected on the day of admission and
cultured for Leptospira organisms, as described previously [3].
Serum samples (5 mL) collected on admission and, if avail-
able, at a 2-week follow-up visit were used for serological
testing. Serum was stored at −80°C between collection and
serological testing. The MAT was performed at the World
Health Organization/United Nations Food and Agriculture
Organization/World Animal Health Organization Collaborating
Center for Reference and Research on Leptospirosis in Brisbane,
Australia. The panel of serovars used in the MAT included
representative serovars from all serogroups known to cause
leptospirosis in Thailand. A real-time PCR assay targeting the
16S rRNA subunit, a lateral ﬂow test (Leptotek, BioMerieux, the
Netherlands), and an in-house IFA were performed as described
previously [2, 11, 12]. The MAT detects crude antibodies against
Leptospira organisms, the lateral ﬂow test detects immunoglobu-
lin M (IgM), and the IFA detects immunoglobulin G, immuno-
globulin A, and IgM [11, 12]. All tests were performed by
experienced technicians. The readers of results of culture, MAT,
and other diagnostic tests in each study were blinded to the
results of the other tests and any clinical information.
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Statistical Analysis
Culture Plus MAT as Gold Standard Model
Five diagnostic tests (culture, MAT, IFA, lateral ﬂow test, and
PCR) were analyzed for each of the studies, using culture plus
MAT as the gold standard. Prevalence, sensitivity, speciﬁcity, and
positive and negative predictive values for each of the 6 tests
were calculated using Stata 11.1 (Stata, College Station, TX).
Bayesian Latent Class Models
Use of latent class models and Bayesian latent class models to
determine the accuracy of diagnostic tests when the accuracy
of the gold standard is imperfect or unknown has been de-
scribed in detail elsewhere [13–15]. Figure 1 illustrates how
the imperfect gold standard model estimates unbiased accura-
cies of diagnostic tests in one example scenario: application of
3 diagnostic tests to 1 study population. In brief, use of Baye-
sian latent class models does not assume that any test or a
combination of any tests is perfect but considers that each test
could be imperfect in diagnosing the true disease status. The
true disease status of the patient population is then deﬁned on
the basis of the overall prevalence (the probability that a
patient with suspected leptospirosis is truly infected) [13–15].
Latent class models estimate the prevalence and accuracy of
each test on the basis of the observed frequency of the possible
combinations of test results.
To estimate the accuracy of a diagnostic test by use of latent
class models, the best-ﬁtting model, as determined by the
presence or absence of correlation between diagnostic tests in
the model, should be used [14, 15]. Possible correlations we
evaluated were based on existing knowledge and external evi-
dence. Therefore, correlation among antigenic tests (culture
and PCR) and correlation among serological tests (MAT, IFA,
and the lateral ﬂow test) were considered. All models assumed
that no prior information (noninformative priors) about the
unknown parameters (ie, prevalence, sensitivities, and speciﬁc-
ities) was available, except that the speciﬁcity of culture was
ﬁxed at 100%. For multicenter studies [4, 5], the models also
assumed that sensitivities and speciﬁcities of culture and MAT
were consistent over different study sites. All parameters and
associated 95% credible intervals (CrIs) were estimated using
WinBUGS 1.4 [16].
To estimate the overall accuracy of culture alone, MAT
alone, and culture plus MAT across all studies, the informa-
tion obtained from the best-ﬁtting Bayesian latent class model
for each data set was combined using a Bayesian meta-analysis
model [17]. Random effects were used to account for differ-
ences in the sensitivities of culture and MAT and the speciﬁ-
city of MAT between studies. The ranges of each parameter
from the Bayesian latent class model with the best ﬁt obtained
for individual data sets were used as informative priors in the
meta-analysis model [17]. Appendixes 1 and 2 (Supplemen-
tary Materials) provide full data sets and all of the models
used, respectively. Appendix 3 (Supplementary Materials) pro-
vides details about the method and the results for the best-
ﬁtting model selection.
Sensitivity Analyses
Sensitivity analyses were performed in which patients without
convalescent-phase samples were excluded and also in which
different prior information were used [18].
RESULTS
The ﬂow diagram in Figure 2 provides an overview of the
study. Five studies conducted by us between 2000 and 2010
that used or evaluated diagnostic tests to investigate patients
Table 1. Characteristics of Populations and Studies in Thailand Included in the Analyses
Studya Authors Province(s) Year Study Design
Sample
Sizeb
Diagnostic
Tests
A Thaipadungpanit
et al [2]
Udon Thani 2000–2001 Prospective,
observational
371 Culture, MAT,
PCR, and LF
B Wuthiekanun et al
[3]
Udon Thani 2000–2002 Prospective,
observational
496 Culture, MAT,
IFA
C Phimda et al [4] Udon Thani, Nakorn Rachasima,
Chaiyapoom, Chumphon
2003–2005 Multicenter,
randomized
controlled trial
314 Culture, MAT
D Wuthiekanun et al
[5]
Udon Thani, Maha Sarakarm, Yasothorn,
Chainut, Rayong, Chanthaburi, Prachuap
Khiri Khun, Phattalung
2003–2004 Multicenter,
prospective,
observational
471 Culture and
MAT
Abbreviations: IFA, immunofluorescence assay; LF, lateral flow test; MAT, microscopic agglutination test; PCR, polymerase chain reaction.
a Studies are ordered chronologically.
b Records of patients for whom not all of the intended tests were performed and records duplicated among studies are excluded.
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presenting to the hospital with suspected leptospirosis were
searched for the presence of complete individual-level data.
One study was excluded because individual test results were
not available [19]. Of 2455 records from the 4 remaining data
sets, 803 were excluded because they were duplicated in ≥1 of
the other studies (n = 641) or because not all of the intended
tests were undertaken (n = 162). Therefore, 4 data sets involv-
ing 1652 patients were included in the analysis (Table 1) [2–5].
Studies A and B were prospective observational studies con-
ducted at a single hospital in Udon Thani, in northeast
Thailand, in which culture, MAT, and at least 1 additional test
(PCR, lateral ﬂow test, or IFA) was undertaken in all cases.
Studies C and D were prospective multicenter studies in which
culture and MAT were undertaken in all cases. All serological
tests had been performed using paired samples, when available.
The median duration of illness prior to admission was 4 days,
and the median duration of illness prior to obtaining the con-
valescent-phase serum sample was 14 days.
We ﬁrst assumed that the combination of culture plus MAT
was a perfect reference test (100% sensitivity and 100% speciﬁ-
city). This gave an estimated prevalence for leptospirosis of
36.9%, 24.0%, 24.8%, and 16.8% for studies A, B, C, and D, re-
spectively. The sensitivity of culture alone was low and varied
signiﬁcantly among studies (28.5%, 28.6%, 15.4%, and 6.3% for
studies A, B, C, and D, respectively). The sensitivity of MAT
was high but also varied signiﬁcantly among studies (86.9%,
85.7%, 91.0%, and 96.2% for studies A, B, C, and D, respective-
ly). PCR, the lateral ﬂow test, and IFA were found to have either
low sensitivity (55.5%, 87.6%, and 64.7%, respectively) or low
speciﬁcity (82.5%, 70.5%, and 95.2%, respectively).
Bayesian latent class models were then used to obtain an
estimate of the accuracy of each diagnostic test, without the
assumption that the reference test was perfect. In the ﬁrst stage,
we deﬁned the best-ﬁtting Bayesian latent class model for each
data set by determining the presence of correlations between
antigenic tests (culture and PCR) and serological tests (MAT,
IFA, and the lateral ﬂow test) (Appendix 3). The best-ﬁtting
model for study A was the model that included correlations
between culture and PCR and between MAT and the lateral
ﬂow test. The best-ﬁtting model for study B was the model
that included correlation between MAT and IFA. The model
without correlation between diagnostic tests was selected for
studies C and D because we did not expect a correlation
between culture and MAT. Sensitivities and speciﬁcities of
culture, MAT, and culture plus MAT, estimated by Bayesian
latent class model for each study, are shown in Figure 3. These
ﬁndings formed the basis for choosing the model with correla-
tion between culture and PCR, between MAT and the lateral
ﬂow test, and between MAT and IFA for the meta-analysis.
Data across all 4 studies were then combined and analyzed
using a Bayesian latent class random-effects meta-analysis
model, which demonstrated that all of the estimated parame-
ters were considerably different from those estimated when
culture plus MAT was assumed to be perfect. The meta-
analysis model indicated that culture, MAT, and culture plus
MAT had very low sensitivities of 10.5% (95% CrI, 2.7%–
27.5%), 49.8% (95% CrI, 37.6%–60.8%), and 55.5% (95% CrI,
42.9%–67.7%), respectively (Figure 3 and Table 2). The speci-
ﬁcity of both MAT alone and of culture plus MAT was 98.8%
(95% CrI, 92.8%–100%). This means that the prevalence of
leptospirosis estimated in each data set using the model was
much higher than if relying on culture plus MAT (eg, 57.4%
vs 36.9% for study A). Of the 2 antigenic tests, PCR had the
highest sensitivity, at 52.7% (95% CrI, 45.2%–60.6%). Among
the 3 serological tests, the lateral ﬂow test had the highest
sensitivity, at 85.6% (95% CrI, 77.5%–93.2%). Because it is
possible that a combination of PCR and a serological test
could be used as point-of-care diagnostic tests for leptospiro-
sis, using positive results of either test, the sensitivity and
speciﬁcity of PCR plus the lateral ﬂow test were calculated by
the model; these were 93.2% (95% CrI, 88.8%–96.9%) and
93.1% (95% CrI, 84.1%–98.5%), respectively (Table 2).
Sensitivity Analysis
Sensitivity analysis was performed in which 555 of 1652 pa-
tients (33.6%) without convalescent-phase samples were
excluded. By use of a random-effects meta-analysis model, the
sensitivities of MAT, the lateral ﬂow test, and IFA were esti-
mated to be 70.3% (95% CrI, 44.1%–91.5%), 89.7% (95% CrI,
80.3%–97.2%), and 71.2% (95% CrI, 52.4%–89.8%), respec-
tively, for patients with leptospirosis who had a convalescent-
phase sample. The accuracies of other diagnostic tests were
not substantially different from the above values, although all
CrIs were wider as a consequence of the reduced information
Figure 1. Schematic illustration of the use of Bayesian latent class model to obtain unbiased estimates of accuracy of diagnostic tests. A, Overview
of all possible outcomes of diagnostic tests, based on true disease status, if 3 diagnostic tests are applied to 1 study population. Broken lines represent
unknown parameters. Patients under evaluation could be either diseased or nondiseased, and prevalence represents the probability that a patient is
diseased. Solid lines represent the application of all 3 diagnostic tests (t1, t2, and t3) to every patient in the study. Test results are conditional on the
sensitivity and speciﬁcity of each test. True disease status (diseased or nondiseased) is a latent variable, as it is not directly observed but can be
estimated as the prevalence in the Bayesian latent class model. B and C, Comparison of how to estimate the accuracy of diagnostic tests, using the
gold standard model (B ) and the imperfect gold standard model (C ).
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Figure 2. Study ﬂow diagram.
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in the sample sizes. There was no substantial change when
different prior information was used (Appendix 4 [Supple-
mentary Data]).
DISCUSSION
The key ﬁndings of this study are that the true sensitivities of
culture, MAT, and culture plus MAT are low. The ﬁnding that
culture has a low sensitivity is neither novel nor surprising,
since Leptospira organisms are only present in the blood
during the ﬁrst week of untreated infection, and isolation of
this bacterium from clinical samples is technically demanding.
Furthermore, our patient population may have consumed
over-the-counter antibiotics prior to hospital presentation,
which may have resulted in false-negative culture results. The
proportion of patients who had taken antibiotics by the time
of presentation in our studies is not known, but a study of
patients presenting to a hospital in neighboring Laos showed
that 57% of patients who were admitted to Mahosot Hospital
and underwent investigations, including lumbar puncture, had
antimicrobial activity detected in their urine [20]. Other possi-
ble explanations for the low sensitivity of culture are that
viable Leptospira species are difﬁcult to recover from clinical
samples, using the existing culture methods. Of note, cultures
were maintained for at least 6 months before results were
deemed to be negative. More worrying is the low sensitivity of
MAT, since this is central to the case deﬁnition of deﬁnite lep-
tospirosis and is widely used.
There are several potential reasons why MAT had low sensi-
tivity in our setting. Antibodies to Leptospira may take several
weeks to become detectable by MAT [21]. In the studies de-
scribed here, the second (ie, convalescent-phase) serum sample
was collected at least 10 days after the start of symptoms that
were attributed to leptospirosis, but it is possible that this
Figure 3. Forest plot of sensitivity and speciﬁcity of culture (A), microagglutination test (MAT; B ), and the combination of culture and MAT (culture +
MAT; C and D ) for leptospirosis estimated by Bayesian latent class models (LCMs) and random-effects meta-analysis models. Squares represent
median estimates of the sensitivities and the speciﬁcities, and the size of the square represents the size of the study. Horizontal lines represent 95%
credible intervals of the estimates. Bayesian LCM assuming conditional dependence between culture and PCR and between MAT and lateral ﬂow (LF)
was used for study A, and Bayesian LCM assuming conditional dependence between MAT and immunoﬂuorescence assay was used for study
B. Bayesian LCM assuming conditional independence between tests and consistency of test accuracies between study sites was used for studies C and
D. Meta-analysis was performed by application of random-effects variables into the combined data set of all 4 studies, assuming conditional depen-
dence between culture and PCR, between MAT and LF, and between MAT and IFA. Abbreviations: IFA, immunoﬂuorescence assay; LCM, latent class
model; LF, lateral ﬂow; MAT, microagglutination test; PCR, polmerase chain reaction.
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Table 2. Prevalence of Leptospirosis and Accuracy of Diagnostic Tests, Determined Using Culture Plus Microagglutination Tests as the
Gold Standard or Bayesian Latent Class and Random-Effects Meta-analysis Models
Parameters Culture Plus MAT as Gold Standard (95% CI)a Bayesian Model (95% CrI)b
Prevalence
Data set A 36.9 (32.0–41.9) 57.4 (49.8–64.3)
Data set B 24.0 (20.3–28.0) 38.1 (27.4–52.2)
Data set C 24.8 (20.2–30.0) 45.9 (34.4–55.5)
Data set D 16.8 (13.5–20.5) 32.6 (21.5–46.9)
Culture
Sensitivity 28.5, 28.6, 15.4, and 6.3* 10.5 (2.7–27.5)
Specificity 100 100
PPV 100 100
NPV 70.5, 81.6, 78.2, and 84.1* 45.6 (37.8–54.7)
MAT
Sensitivity 86.9, 85.7, 91.0, and 96.2* 49.8 (37.6–60.8)
Specificity 100 98.8 (92.8–100)
PPV 100 98.3 (88.4–100)
NPV 92.9, 95.7, 97.1, and 99.2* 59.2 (49.8–68.4)
Culture plus MATc
Sensitivity 100 55.5 (42.9–67.7)
Specificity 100 98.8 (92.8–100)
PPV 100 98.5 (89.6–100)
NPV 100 62.0 (52.1–72.2)
PCRd
Sensitivity 55.5 (46.7–64.0) 52.7 (45.2–60.6)
Specificity 82.5 (77.0–87.1) 97.2 (92.0–99.8)
PPV 65.0 (56.2–73.7) 96.2 (88.5–99.8)
NPV 76.0 (70.7–81.3) 60.4 (51.5–69.2)
LFd
Sensitivity 87.6 (80.9–92.6) 85.6 (77.5–93.2)
Specificity 70.5 (64.2–76.3) 96.2 (87.7–99.8)
PPV 63.5 (56.6–70.4) 96.9 (88.9–99.9)
NPV 90.7 (86.4–94.9) 83.3 (72.2–92.5)
PCR plus LFc,d
Sensitivity 92.7 (87.0–96.4) 93.2 (88.8–96.9)
Specificity 66.2 (59.8–72.3) 93.1 (84.1–98.5)
PPV 61.7 (55.0–68.3) 94.9 (86.8–99.0)
NPV 93.9 (90.3–97.6) 91.1 (83.4–96.2)
IFAd
Sensitivity 64.7 (55.4–73.2) 45.5 (33.3–60.9)
Specificity 95.2 (92.5–97.1) 96.8 (92.8–99.8)
PPV 81.1 (71.7–88.4) 95.2 (87.8–99.7)
NPV 89.5 (86.1–92.3) 57.1 (47.3–68.2)
Abbreviations: CI, confidence interval; CrI, credible interval; IFA, immunofluorescence assay; LF, lateral flow test; MAT, microscopic agglutination test; NPV, negative
predictive value; PCR, polymerase chain reaction; PPV, positive predictive value.
*For studies A, B, C, and D, respectively.
a Values were estimated on the basis of the observed proportion, which was determined by assuming that culture plus MAT is the gold standard (ie, 100%
sensitive and 100% specific). The 95% confidence intervals were obtained using Stata 11.1 (Stata).
b Values were estimated using Bayesian latent class and random-effects meta-analysis models, assuming that culture plus MAT is imperfect. Posterior estimates
and 95% credible intervals of each parameter were obtained in WinBUGs from 10 000 iterations of each of 2 chains, starting from different initial values
following a burn-in period of 5000 iterations.
c Positive results of one or both tests is diagnostic for leptospirosis infection.
d Values calculated by assuming that culture plus MAT is the gold standard were based on data from studies A and B, whereas values calculated by the Bayesian
model were estimated from a meta-analysis model, using the data set for all 4 studies combined.
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interval was too short in some cases [22]. In common with
other research studies and reﬂecting real life, we also failed to
obtain a convalescent-phase serum specimen from 34% of pa-
tients, either because they died or because they were discharged
and were lost to follow-up. The results from our sensitivity anal-
ysis also show that the sensitivity of MAT was 70.3% in the ideal
situation, in which convalescent-phase samples were obtained
from all patients. This increase in sensitivity is consistent with
existing knowledge and is comparable to a previous estimate
(76%), in which only patients with culture-conﬁrmed leptospi-
rosis were considered [22]. However, this also suggests that a
number of patients with leptospirosis have a false-negative test
result by MAT even if a convalescent-phase sample is available.
Other possible explanations for the low sensitivity of MAT are
that lipopolysaccharide from different Leptospira serovars
induces a variable level of immune response and that the Leptos-
pira serovars used in the MAT did not include 1 or more locally
important strains, although we have no evidence that this is the
case. The poor sensitivity of culture plus MAT in the real clini-
cal setting, as shown by Bayesian latent class modeling, suggests
that improvement of both tests or development of a new gold
standard test is required.
Our data supported a positive correlation between both
antigenic tests (ie, culture and PCR), a ﬁnding that could be in-
terpreted as meaning that results of both culture and PCR are
more likely to be positive if the burden of Leptospira organisms
in blood is high and to be negative if the burden is low [2, 23]. A
positive correlation was also found between serological tests (ie,
between MAT and IFA and between MAT and the lateral ﬂow
test). These ﬁndings are consistent with existing knowledge.
A major effect of poor sensitivity of the reference test is that
the prevalence of leptospirosis is underestimated. The estimated
prevalence of leptospirosis for each study separately, as deter-
mined by Bayesian latent class modeling (32.6%–57.4%), was
around double that of previous estimates that used culture plus
MAT as the gold standard (16.8%–36.9%). This is credible, since
50% of our study patients with suspected leptospirosis left the
hospital without a deﬁnite diagnosis following a test panel that
included bacterial culture; other serological tests, including those
for rickettsial infections (which are also common in our setting);
radiological tests; and detailed clinical evaluation [2–5]. Our
study suggests that leptospirosis may have been the cause of fever
in a proportion of these cases.
Evaluation of diagnostic tests when the accuracy of the gold
standard is unknown is an active area of biostatistical research,
since the use of an imperfect gold standard to evaluate the
accuracy and clinical usefulness of an alternative test is ﬂawed
and leads to biased results [8, 14, 17, 24]. Our study has dem-
onstrated that culture plus MAT represents a relatively poor
gold standard against which to compare alternative diagnostic
tests for leptospirosis and has shown the usefulness of
statistical models under such circumstances. For example,
PCR had a sensitivity and speciﬁcity of 55.5% and 82.5%, re-
spectively, when compared with culture plus MAT. When re-
calculated using Bayesian latent class modeling, the sensitivity
and speciﬁcity of PCR were 52.7% and 97.2%, respectively,
representing a test with a high degree of speciﬁcity.
Our study had several strengths, including the use of large
and individual-level data sets rather than summary estimates
from the published literature. Disparity of study characteristics
and risk of bias were comparatively low, since all studies were
conducted prospectively and by the same research unit. None
of the studies were supported by diagnostic companies. In ad-
dition, we used a random-effects model, a rigorous statistical
method that has been recommended by the Cochrane Diag-
nostic Test Accuracy Working Group as the method of choice
for diagnostic meta-analyses [10].
This study also has several limitations. Use of basic Bayesian
latent class models to estimate the sensitivity and speciﬁcity of
each test in a population does not allow us to determine the
effects that symptom duration, antimicrobials received prior to
presentation, and timing of convalescent-phase samples at the
level of individual patients have on these parameters. These
effects could be evaluated in advanced Bayesian latent class
models [25]. Correlation between IFA and the lateral ﬂow test
could not be evaluated because these tests were not performed
together in any study included in the analysis. The small number
of studies included also meant that important study characteris-
tics, including differences in the prevalence of leptospirosis, and
the level of reproducibility between studies of the ﬁnding of high
accuracy for PCR and the lateral ﬂow test were not assessed. The
commercial lateral ﬂow test evaluated here had a published speci-
ﬁcity that was underestimated, compared with the gold standard,
but it is not currently available [26, 27]. The currently available
rapid serological tests for leptospirosis include a latex agglutina-
tion test and an IgM enzyme-linked immunosorbant assay [28–
30], neither of which has been evaluated by us to date.
We conclude that our current reference testing strategy is
imperfect. As a result, both the prevalence of leptospirosis in
northeast Thailand and the accuracy of alternative diagnostic
tests have been underestimated. There is an urgent need for
rapid serological tests for leptospirosis. Our ﬁndings support
the use of latent class models to evaluate such a new test
against an imperfect gold standard.
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